Dr Reddy’s Wants To Break Into Top Five In India
Expects China Market Uptick, India Sputnik V Go-Ahead In March
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
